Ticlovas 250mg Tablet
Marketer
USV Ltd
Salt Composition
Ticlopidine (250mg)
Overview Ticlovas 250mg Tablet
Dipyridamole 250mg tablets are prescribed to mitigate stroke risk in patients unresponsive to or unsuitable for aspirin therapy. This antiplatelet agent, a blood thinner, reduces harmful clot formation within blood vessels, thus lowering recurrent stroke probability in individuals with a prior stroke or transient ischemic attack (TIA). It's also sometimes co-administered with aspirin post-angioplasty (stent insertion) to prevent stent thrombosis. For optimal efficacy, take with food daily at the same time. Consistent use is crucial; discontinuation elevates stroke risk. Common side effects include nausea, vomiting, diarrhea, abdominal pain, skin rash, and leukopenia. Bleeding complications, manifesting as bruising, epistaxis, hematuria, melena, or heavier menses, are possible. Report persistent or concerning bleeding immediately. This medication is contraindicated in individuals with active bleeding (e.g., peptic ulcer, intracranial hemorrhage), hepatic impairment, or hematological disorders (e.g., aplastic anemia, neutropenia). Pre-treatment and periodic complete blood counts (CBCs) are necessary, and temporary cessation may be required before procedures.
Uses of Ticlovas 250mg Tablet
Preventing Cerebrovascular Accidents
Major Benefits of Ticlovas 250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the 250mg Ticlovas tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
Common Side effects of Ticlovas 250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Rash
- Decreased white blood cell count
How to use Ticlovas 250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 250mg Ticlovas tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
How Ticlovas 250mg Tablet works:
Aggrenox 250mg tablets inhibit platelet aggregation, thus reducing the risk of dangerous thrombus development and consequently minimizing the likelihood of cerebrovascular accident or myocardial infarction.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Ticlovas 250mg tablets is inadvisable.
PregnancySAFE IF PRESCRIBED
Pregnant individuals may generally use Ticlovas 250mg tablets without significant safety concerns. Animal research indicates minimal or no negative impacts on fetal development; however, data from human trials are scarce.
Breast feedingCONSULT YOUR DOCTOR
The use of Ticlovas 250mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a Ticlovas 250mg tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ticlovas 250mg tablets to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Patients with liver impairment should use Ticlovas 250mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. Liver function should be regularly monitored during treatment.
What if you forget to take Ticlovas 250mg Tablet :
Should you forget a Ticlovas 250mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ticlovas 250mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Thienopyridine compound |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Category | ADP receptor antagonists (P2Y12 inhibitors) |
3,018 People bought this recently